Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05197127 · ClinicalTrials.gov registry record · NA
Efficacy of Samsung GEMS-H Device Training in Older Adults
A NA study, sponsored by Shirley Ryan AbilityLab.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT05197127: Completed NA study, sponsored by Shirley Ryan AbilityLab.
NCT05197127 is a NA study that has completed, run by Shirley Ryan AbilityLab. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05197127, a NA study, has completed, sponsored by Shirley Ryan AbilityLab.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the feasibility of using Samsung robotic hip assist-based mobility intervention for older adults with frailty. The specific aims of this project are: Aim 1 Will investigate the feasibility of the Samsung robotic hip assist-based mobility intervention on gait function, sedentary time, and fall risk. Hypothesis: A 6-week robotic device-based mobility intervention will improve locomotor gait function, sedentary time, and fall risk.
Primary Outcome
Average walking speed measured over 10 meters, tested at self selected velocity and fast velocity
Interventions
- DEVICE exoskeleton-based gait training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2018-09-14 |
| Est. Completion | 2019-05-07 |
| Phase | NA |
What the finished NCT05197127 record still lists
NCT05197127 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which exoskeleton-based gait training is the first listed.
NCT05197127 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05197127 about?
NCT05197127 is a clinical study titled "Efficacy of Samsung GEMS-H Device Training in Older Adults". The purpose of this study is to evaluate the feasibility of using Samsung robotic hip assist-based mobility intervention for older adults with frailty. The specific aims of this project are: Aim 1 Will investigate the feasibility of the Samsung robotic hip assist-based mobility intervention on gai...
What is the current status of trial NCT05197127?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2018-09-14. Estimated completion is 2019-05-07.
What interventions are being tested in trial NCT05197127?
The interventions under investigation include: exoskeleton-based gait training (DEVICE).
Who is sponsoring clinical trial NCT05197127?
This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05197127's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI